AVLSA
IMA
Atlas Venture Life Science Advisors’s ImageneBio, Inc. Common Stock IMA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.72M | Hold |
5,018,178
| – | – | 1.02% | 9 |
|
2025
Q1 | $6.42M | Hold |
5,018,178
| – | – | 1.23% | 9 |
|
2024
Q4 | $8.23M | Hold |
5,018,178
| – | – | 1% | 9 |
|
2024
Q3 | $8.68M | Hold |
5,018,178
| – | – | 0.8% | 11 |
|
2024
Q2 | $8.28M | Hold |
5,018,178
| – | – | 0.87% | 11 |
|
2024
Q1 | $7.13M | Hold |
5,018,178
| – | – | 0.66% | 12 |
|
2023
Q4 | $9.89M | Hold |
5,018,178
| – | – | 1.18% | 11 |
|
2023
Q3 | $21.7M | Hold |
5,018,178
| – | – | 3.37% | 10 |
|
2023
Q2 | $32.9M | Hold |
5,018,178
| – | – | 4.1% | 10 |
|
2023
Q1 | $17.3M | Hold |
5,018,178
| – | – | 2.34% | 11 |
|
2022
Q4 | $13.3M | Hold |
5,018,178
| – | – | 1.61% | 11 |
|
2022
Q3 | $17.8M | Hold |
5,018,178
| – | – | 1.97% | 10 |
|
2022
Q2 | $22.2M | Hold |
5,018,178
| – | – | 3.72% | 7 |
|
2022
Q1 | $30.6M | Hold |
5,018,178
| – | – | 3.87% | 9 |
|
2021
Q4 | $62.9M | Buy |
+5,018,178
| New | +$62.9M | 5.78% | 5 |
|